Fla. Stat. 461.0134
Prescription or administration of dimethyl sulfoxide (DMSO); written release and information requirements

(1)

A podiatric physician licensed under this chapter may not be subject to disciplinary action by the board for prescribing or administering dimethyl sulfoxide (DMSO) to a patient under the podiatric physician’s care who has requested the substance as long as the podiatric physician complies with the requirements of this section.

(2)

The patient, after being fully informed as to alternative methods of treatment and their potential for cure and upon request for the administration of dimethyl sulfoxide (DMSO) by the patient’s podiatric physician, shall sign a written release, releasing the podiatric physician and, when applicable, the hospital or health facility from any liability therefor.

(3)

The podiatric physician shall inform the patient in writing if dimethyl sulfoxide (DMSO) has not been approved as a treatment or cure by the Food and Drug Administration of the United States Department of Health and Human Services for the disorder for which it is being prescribed.

Source: Section 461.0134 — Prescription or administration of dimethyl sulfoxide (DMSO); written release and information requirements, https://www.­flsenate.­gov/Laws/Statutes/2024/0461.­0134 (accessed Aug. 7, 2025).

Current through Fall 2025

§ 461.0134. Prescription or administration of dimethyl sulfoxide (DMSO); written release & information requirements's source at flsenate​.gov